Ang II and EGF synergistically induce COX-2 expression via CREB in intestinal epithelial cells

Journal of Cellular Physiology

Volumn 214, Issue 1, 2008, Pages 96-109

  Pham, Hung ^a   Chong, Benny ^a   Vincenti, Romina ^a   Slice, Lee W ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CYCLOOXYGENASE 2; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN; RNA;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; INTESTINE CELL; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CULTURE MEDIA, SERUM-FREE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOOXYGENASE 2; DINOPROSTONE; DRUG SYNERGISM; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EPOPROSTENOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTESTINES; LUCIFERASES; MODELS, BIOLOGICAL; RATS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

RATTUS;

EID: 36849036396     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21167     Document Type: Article

References (66)

1. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. 1996. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97:2672-2679.
2. Buchanan FG, Wang D, Bargiacchi F, DuBois RN. 2003. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 278:35451-35457.
3. Chiu T, Rozengurt E. 2001. PKD in intestinal epithelial cells: Rapid activation by phorbol esters, LPA, and angiotensin through PKC. Am J Physiol Cell Physiol 280:C929-C942.
4. Chiu T, Santiskulvong C, Rozengurt E. 2003. ANG II stimulates PKC-dependent ERK activation, DNA synthesis, and cell division in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 285:G1-G11.
5. Chiu T, Santiskulvong C, Rozengurt E. 2005. EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway. Am J Physiol Gastrointest Liver Physiol 288:G182-G194.
6. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859.
7. Conkright MD, Guzman E, Flechner L, Su AI, Hogenesch JB, Montminy M. 2003. Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol Cell 11:1101-1108.
8. Cuenda A, Alonso G, Morrice N, Jones M, Meier R, Cohen P, Nebreda AR. 1996. Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells. EMBO J 15:4156-4164.
9. Daub H, Weiss FU, Wallasch C, Ullrich A. 1996. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557.
10. Dean JL, Brook M, Clark AR, Saklatvala J. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 274:264-269.
11. DeLong P, Tanaka T, Kruklitis R, Henry AC, Kapoor V, Kaiser LR, Sterman DH, Albelda SM. 2003. Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy. Cancer Res 63:7845-7852.
12. Denli AM, Hannon GJ. 2003. RNAi: An ever-growing puzzle. Trends Biochem Sci 28:196-201.
13. DuBois RN, Tsujii M, Bishop P, Awad JA, Makita K, Lanahan A. 1994. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am J Physiol 266:G822-G827.
14. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. 1998. Cyclooxygenase in biology and disease. FASEB J 12:1063-1073.
15. Duggan KA, Mendelsohn FA, Levens NR. 1989. Angiotensin receptors and angiotensin 1-converting enzyme in rat intestine. Am J Physiol 257:G504-G510.
16. Eberhart CE, Dubois RN. 1995. Eicosanoids and the gastrointestinal tract. Gastroenterology 109:285-301.
17. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188.
18. Eguchi S, Inagami T. 2000. Signal transduction of angiotensin II type I receptor through receptor tyrosine kinase. Regul Pept 91:13-20.
19. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T. 1998. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896.
20. Gallo KA, Johnson GL. 2002. Mixed-lineage kinase control of jnk and p38 mapk pathways. Nature Rev Mol Cell Biol 3:663.
21. Guo YS, Hellmich MR, Wen XD, Townsend CM, Jr. 2001. Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J Biol Chem 276:22941-22947.
22. Hamberg M, Samuelsson B. 1967. On the mechanism of the biosynthesis of prostaglandins E-1 and F-1-alpha. J Biol Chem 242:5336-5343.
23. Hirasawa K, Sato Y, Hosoda Y, Yamamoto T, Hanai H. 2002. Immunohistochemical localization of angiotensin II receptor and local renin-angiotensin system in human colonic mucosa. J Histochem Cytochem 50:275-282.
24. Impey S, McCorkle SR, Cha-Molstad H, Dwyer JM, Yochum GS, Boss JM, McWeeney S, Dunn JJ, Mandel G, Goodman RH. 2004. Defining the CREB reguion: A genome-wide analysis of transcription factor regulatory regions. Cell 119:1041-1054.
25. Inoue H, Taba Y, Miwa Y, Yokota C, Miyagi M, Sasaguri T. 2002. Transcriptional and posttranscriptional regulation of cyclooxygenase-2 expression by fluid shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol 22:1415-1420.
26. Kawamori T, Rao CV, Seibert K, Reddy BS. 1998. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58:409-412.
27. Kirk GR, Clements WD. 1999. Crohn's disease and colorectal malignancy. Int J Clin Pract 53:314-315.
28. Konig P, Richmond TJ. 1993. The X-ray structure of the GCN4-bZIP bound to ATF/CREB site DNA shows the complex depends on DNA flexibility. J Mol Biol 233:139.
29. Koon H-W, Zhao D, Zhan Y, Rhee SH, Moyer MP, Pothoulakis C. 2006. Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells. J Immunol 176:5050-5059.
30. Lewis JD, Deren JJ, Lichtenstein GR. 1999. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am 28:459-477, x.
31. Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T. 2001. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 276:18563-18569.
32. Mayer A, Takimoto M, Fritz E, Schellander G, Kofier K, Ludwig H. 1993. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 71:2454-2460.
33. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609.
34. McManus MT, Sharp PA. 2002. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 3:737-747.
35. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. 2005. Genes that mediate breast cancer metastasis to lung. Nature 436:518-524.
36. Moran AE, Hunt DH, Javid SH, Redston M, Carothers AM, Bertagnolli MM. 2004. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice. J Biol Chem 279:43261-43272.
37. Morita I. 2002. Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat 68-69:165-175.
38. Morris JK, Richards JS. 1996. An E-box region within the prostaglandin endoperoxide synthase-2 (PGS-2) promoter is required for transcription in rat ovarian granulosa cells. J Biol Chem 271:16633-16643.
39. Musa-Aziz R, Mello-Aires M. 2005. Action of ANG II and ANP on colon epithelial cells. Pflugers Arch 450:405-414.
40. Mynard V, Latchoumanin O, Guignat L, Devin-Leclerc J, Bertagna X, Barre B, Fagart J, Coqueret O, Catelli MG. 2004. Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3′,5′-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter. Mol Endocrinol 18:2997-3010.
41. Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K. 2001. Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci USA 98:7629-7634.
42. Pham H, Shafer LM, Slice LW. 2006. CREB-dependent cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression is mediated by protein kinase C and calcium. J Cell Biochem 98:1653-1666.
43. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A. 1999. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884-888.
44. Quaroni A, Wands J, Trelstad RL, Isselbacher KJ. 1979. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol 80:248-265.
45. Rigas B, Goldman IS, Levine L. 1993. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122:518-523.
46. Shafer LM, Slice LW. 2005. Anisomycin induces COX-2 mRNA expression through p38(MAPK) and CREB independent of small GTPases in intestinal epithelial cells. Biochim Biophys Acta 1745:393-400.
47. Sharon P, Ligumsky M, Rachmilewitz D, Zor U. 1978. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 75:638-640.
48. Shaywitz AJ, Greenberg ME. 1999. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821-861.
49. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF. 1998. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115:297-306.
50. Slice LW, Bui L, Mak C, Walsh JH. 2000. Differential regulation of COX-2 transcription by Ras- and Rho-family of GTPases. Biochem Biophys Res Commun 276:406-410.
51. Slice LW, Hodikian R, Zhukova E. 2003. Gastrin and EGF synergistically induce cyclooxygenase-2 expression in Swiss 3T3 fibroblasts that express the CCK2 receptor. J Cell Physiol 196:454-463.
52. Slice LW, Chiu T, Rozengurt E. 2005. Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through small GTPases using distinct signaling pathways. J Biol Chem 280:1582-1593.
53. Smith WL, Marnett LJ. 1991. Prostaglandin endoperoxide synthase: Structure and catalysis. Biochim Biophys Acta 1083:1-17.
54. Subbaramaiah K, Chung WJ, Dannenberg AJ. 1998. Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J Biol Chem 273:32943-32949.
55. Tarnawski AS, Jones MK. 1998. The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: Involvement of EGF-R signal transduction pathways. J Clin Gastroenterol 27:S12-S20.
56. Thuresson ED, Lakkides KM, Smith WL. 2000. Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products. J Biol Chem 275:8501-8507.
57. Torrance CJ, Jackson PE, Montgomery E, Kinzler KW, Vogelstein B, Wissner A, Nunes M, Frost P, Discafani CM. 2000. Combinatorial chemoprevention of intestinal neoplasia. Nat Med 6:1024-1028.
58. Tsai A, Kulmacz RJ, Palmer G. 1995. Spectroscopic evidence for reaction of prostaglandin H synthase-1 tyrosyl radical with arachidonic acid. J Biol Chem 270:10503-10508.
59. Wang D, Mann JR, DuBois RN. 2005a. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 128:1445-1461.
60. Wang G, Balamotis MA, Stevens JL, Yamaguchi Y, Handa H, Berk AJ. 2005b. Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. Mol Cell 17:683-694.
61. Wu SS, Yamauchi K, Rozengurt E. 2005. Bombesin and angiotensin II rapidly stimulate Src phosphorylation at Tyr-418 in fibroblasts and intestinal epithelial cells through a PP2-insensitive pathway. Cell Signal 17:93-102.
62. Xie W, Herschman HR. 1995. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem 270:27622-27628.
63. Xie W, Herschman HR. 1996. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J Biol Chem 271:31742-31748.
64. Xie W, Fletcher BS, Andersen RD, Herschman HR. 1994. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol Cell Biol 14:6531-6539.
65. Yamamoto KK, Gonzalez GA, Biggs WH, Montminy MR. 1988. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334:494.
66. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, Chen H, Jenner R, Herbolsheimer E, Jacobsen E, Kadam S, Ecker JR, Emerson B, Hogenesch JB, Unterman T, Young RA, Montminy M. 2005. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 102:4459-4464.